Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?

BMC Gastroenterology

Volumn 14, Issue 1, 2014, Pages

  Rey, Enrique ^a   Barceló, Marta ^a   Zapardiel, Javier ^b   Sobreviela, Eduardo ^c   Muñoz, Mercedes ^d   Díaz Rubio, Manuel ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL INFANTA ELENA   (Spain)

^c IQVIA   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

GERD; Heartburn; Patient reported outcomes; Questionnaires

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRINKING BEHAVIOR; EATING DISORDER; EPIGASTRIC BURNING; EPIGASTRIC PAIN; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM RATING SCALE; GERD IMPACT SCALE; HEARTBURN; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON TROUBLESOME SYMPTOM; PREDICTIVE VALUE; QUALITY OF LIFE; QUALITY OF LIFE IN REFLUX AND DYSPEPSIA; QUESTIONNAIRE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; REFLUX DISEASE QUESTIONNAIRE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; SYMPTOM; SYMPTOM ASSESSMENT; THORAX PAIN; TROUBLESOME SYMPTOM; BODY MASS; CLINICAL EVALUATION; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ASSOCIATION; SYMPTOMATOLOGY;

ADULT; AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; LARYNGOPHARYNGEAL REFLUX; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; QUESTIONNAIRES; ROC CURVE; SPAIN;

EID: 84892659627     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-14-17     Document Type: Article

References (32)

1. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, et al. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004, 19(1):95-105. 10.1046/j.1365-2036.2003.01769.x, 14687171.
2. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112(5):1448-56. 10.1016/S0016-5085(97)70025-8, 9136821.
3. Rey E, Moreno-Elola-Olaso C, Rodriguez-Artalejo F, et al. Medical consultation for gastro-oesophageal reflux symptoms: reasons and associated factors. Digestion 2004, 70(3):173-7. 10.1159/000081626, 15492482.
4. Bretagne JF, Honnorat C, Richard-Molard B, et al. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther 2006, 23(5):607-16. 10.1111/j.1365-2036.2006.02811.x, 16480400.
5. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101(8):1900-20. 10.1111/j.1572-0241.2006.00630.x, 16928254.
6. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006, 101(1):18-28. 10.1111/j.1572-0241.2005.00343.x, 16405529.
7. Wright CE, Ebrecht M, Mitchell R, et al. The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res 2005, 59(6):415-24. 10.1016/j.jpsychores.2005.05.012, 16310024.
8. Marzo M, Alonso P, Bonfill X. [Clinical practice guideline on the management of patients with gastroesophageal reflux disease (GERD)]. Gastroenterol Hepatol 2002, 25(2):85-110. 10.1016/S0210-5705(02)70245-8, 11841764.
9. Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol 2005, 19(1):15-35.
10. Bytzer P. Assessment of reflux symptom severity: methodological options and their attributes. Gut 2004, 53(Suppl 4):iv28-iv34. 1867778, 15082611.
11. McColl E, Junghard O, Wiklund I, et al. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?. Am J Gastroenterol 2005, 100(1):11-8. 10.1111/j.1572-0241.2005.40945.x, 15654774.
12. Fallone CA, Guyatt GH, Armstrong D, et al. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?. Aliment Pharmacol Ther 2004, 20(10):1161-9. 10.1111/j.1365-2036.2004.02257.x, 15569119.
13. Shaw M, Dent J, Beebe T, et al. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008, 6:31. 10.1186/1477-7525-6-31, 2390523, 18447946.
14. Nuevo J, Tafalla M, Zapardiel J. [Validation of the Reflux Disease Questionnaire (RDQ) and Gastrointestinal Impact Scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population]. Gastroenterol Hepatol 2009, 32(4):264-73. 10.1016/j.gastrohep.2008.12.004, 19371971.
15. Jones R, Coyne K, Wiklund I. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007, 25(12):1451-9. 10.1111/j.1365-2036.2007.03343.x, 17539985.
16. Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut 2010, 59(6):714-21. 10.1136/gut.2009.200063, 20551454.
17. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994, 69(6):539-47. 10.1016/S0025-6196(12)62245-9, 8189759.
18. Moreno Elola-Olaso C, Rey E, Rodriguez-Artalejo F, et al. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enferm Dig 2002, 94(12):745-58.
19. Jo SY, Kim N, Lim JH, et al. Comparison of gastroesophageal reflux disease symptom and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire. J Neurogastroenterol Motil 2013, 19:61-69. 10.5056/jnm.2013.19.1.61, 3548129, 23350049.
20. Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 1998, 7(1):75-83.
21. Kulich KR, Pique JM, Vegazo O. [Psychometric validation of translation to Spanish of the gastrointestinal symptoms rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) in patients with gastroesophageal reflux disease]. Rev Clin Esp 2005, 205(12):588-94. 10.1016/S0014-2565(05)72651-5, 16527180.
22. Wiklund IK, Junghard O, Grace E, et al. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998, 583:41-9.
23. Flook N, Jones R, Vakil N. Approach to gastroesophageal reflux disease in primary care: putting the Montreal definition into practice. Can Fam Physician 2008, 54(5):701-5. 2377200, 18474703.
24. Reimer C, Bytzer P. Perceptions and beliefs concerning gastroesophageal reflux disease: physicians and patients disagree. Digestion 2007, 76(3-4):229-34.
25. Bai Y, Du J, Zou D. Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real- world practice: a national multicenter survey on 8065 patients. J Gastroenterol Hepatol 2013, doi:10.1111/jgh.12125 [Epubhead of print]).
26. Reimer C, Bytzer P. A population-based survey to assess troublesome symptoms in gastroesophageal reflux disease. Scand J Gastroenterol 2009, 44(4):394-400. 10.1080/00365520802600987, 19065448.
27. Schey R, Dichman R, Parthasarathy S, et al. Sleep deprivation hyperalgesic in patienes with gastroesophageal reflux disease. Gastroenterology 2007, 133:1787-1795. 10.1053/j.gastro.2007.09.039, 18054551.
28. Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a casual link and therapeutic implications. J Neurogastroenterol Motil 2010, 16:22-29. 10.5056/jnm.2010.16.1.22, 2879818, 20535322.
29. Orr WC, Goodrich S, Fernsröm P, et al. Occurrence of nighttime gastroesopahgeal reflux in disturbed and normal sleepers. Clin Gastroenterol Hepatol 2008, 6:1099-1104. 10.1016/j.cgh.2008.06.016, 18928935.
30. Ponce J, Vegazo O, Beltran B, et al. Prevalence of gastro-oesophageal reflux disease in Spain and associated factors. Aliment Pharmacol Ther 2006, 23(1):175-84. 10.1111/j.1365-2036.2006.02733.x, 16393295.
31. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol 2009, 43(2):111-7. 10.1097/MCG.0b013e31815ea27b, 18838922.
32. Madalosso CA, Fornari F, Callegari-Jacques SM, et al. Performance of the Montreal consensus in the diagnosis of gastroesophageal reflux disease in morbidly obese patients. Obes Surg 2008, 18(6):668-74. 10.1007/s11695-008-9462-6, 18322762.